title: Topical tacrolimus for effective treatment of eosinophilic folliculitis associated with human immunodeficiency virus infection.
authors.affiliation: Department of Dermatology and Venereology, Division of Infectious Disease, University Hospital Geneva, Geneva, Switzerland. laurence.trellu@hcuge.ch
authors.forename: Laurence
authors.initials: L
authors.lastname: Toutous-Trellu
authors.forename: Shahnaz
authors.initials: S
authors.lastname: Abraham
authors.forename: Marc
authors.initials: M
authors.lastname: Pechère
authors.forename: Pierre
authors.initials: P
authors.lastname: Chavaz
authors.forename: Jan
authors.initials: J
authors.lastname: Lübbe
authors.forename: Véronique
authors.initials: V
authors.lastname: Schiffer
authors.forename: Bernard
authors.initials: B
authors.lastname: Hirschel
authors.forename: Jean-Hilaire
authors.initials: JH
authors.lastname: Saurat
authors.forename: Vincent
authors.initials: V
authors.lastname: Piguet
mesh_terms: D000287:Administration, Topical; D000328:Adult; D004802:Eosinophilia / Q000188:drug therapy* / Q000473:pathology / Q000821:virology*; D005260:Female; D005499:Folliculitis / Q000188:drug therapy* / Q000473:pathology / Q000821:virology*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D016559:Tacrolimus / Q000008:administration & dosage* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus